56939EGP
- Active ingredient
- darolutamide
- Strength
- 300 mg
- Form
- tablet
- Manufacturer
- bayer
- Route
- oral.solid
Uses
Treatment of non-metastatic castration-resistant prostate cancer and metastatic castration-sensitive prostate cancer.
Do not use if
No specific absolute contraindications listed in prescribing information.
Side effects
Fatigue, rash, constipation, elevated liver enzymes, and laboratory abnormalities may occur.
Warnings
Monitor for cardiovascular events and seizures. Use under specialist supervision.
How it works
An androgen receptor inhibitor that blocks androgen signaling involved in prostate cancer growth.
Storage
Store at 20–25°C and keep the bottle tightly closed.